✦ LIBER ✦

Epirubicin (E) plus paclitaxel (P) vs epirubicin followed by paclitaxel in metastatic breast cancer (MBC): An ongoing pharmacoeconomic study

✍ Scribed by A. Redaelli; E. Baldini; B. Salvadori; P.F. Conte; F. Carnino; M. Guameri; M. Svanosio; V. Dongiovanni

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epirubicin (E) plus paclitaxel (P) vs ep

✍ Redaelli, A.; Baldini, E.; Salvadori, B.; Aldrighetti, D.; Conte, P.F.; Quattroc 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Multicenter randomized phase III trial o

✍ Baldini, E; Prochilo, T; Salvadori, B; Bolognesi, A; Aldrighetti, D; Venturini, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

1–37 Multicenter Randomized Phase III Tr

✍ Seidman, A.D. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Adjuvant treatment of breast cancer pati

✍ D. Elling; H. Eggemann; S. Kümmel; P. Breitbach; A. Kohls; G. Morack; H. Schloss 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 93 KB

PP-7-6 Dose dense epirubicin (E) and pac

✍ J. Nortier; J. Wils; F. Erdkamp; R. Lalisang; J. Wals; H. Hillen; G. Blijham 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 175 KB

122 O - A phase I trial of epirubicin (E

✍ R. Salyadori; A. Mlchelotti; E. Baldini; A. Gennari; C. Tibaldi; A. Tognani; P.G 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 167 KB